Our study first reported the carcinogenic and cancer‐promoting effects of TMEM92‐AS1 in GC and showed that TMEM92‐AS1 regulated the expression of CCL5 by binding to YBX1 to exert function. The gene discussed is TMEM92; the disease is gastric cancer.